People · Operator
Named in public records as an officer, director or promoter · active 2009–2012 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sientra, Inc. | — | Other Health Care | Series C | $65.0M | $1.5B | 2012 |
| QUATRX PHARMACEUTICALS Co | — | Pharmaceuticals | Series A | $14.0M | $434.4M | 2009 |
| ARYx Therapeutics, Inc. | — | Pharmaceuticals | Seed | $2.4M | $76.6M | 2010 |
Nick Simon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nick Simon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rishi Gupta | 1 | 12 |
| Patrick Heron | 1 | 11 |
| PAUL SEKHRI | 1 | 7 |
| Chris Ehrlich | 1 | 6 |
| Robert Adelman | 1 | 5 |
| Anders Hove | 1 | 4 |
| Paul Goddard | 1 | 4 |
| Keith Leonard | 1 | 3 |
| Lars G. Ekman | 1 | 3 |
| Joel Smith | 1 | 3 |
| Christopher Nicholas | 1 | 2 |
| Rick Fox | 1 | 2 |
| Robert L. Zerbe | 1 | 2 |
| Peter G Milner | 1 | 2 |
| Paul G. Sekhri | 1 | 2 |
| Pascal Druzgala | 1 | 2 |
| Matthew Pigeon | 1 | 2 |
| Lars Ekman | 1 | 2 |
| Herm G. Rosenman | 1 | 1 |
| David G. Beier | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.